Devices

The oldest chronic brain implant in routine clinical use. Benabid's 1987 thalamic stimulation for tremor, FDA approval for tremor in 1997, Parkinson's targets in 2002 or 2003 depending on the source, and humanitarian exemptions for dystonia and OCD.

Device — Other

Deep brain stimulation (history)

Official site →

DBS · deep brain stimulation · Parkinson's · essential tremor · dystonia · history · academic · human

Deep brain stimulation (history)

One-line verdict: The clinical baseline for any brain implant that records or stimulates: decades of use, a pacemaker-like pulse generator, and a mechanism that is still debated.

Quick tags: Stimulation · Deep brain · Human · Modern era from 1987

Overview

What it is: A device similar to a cardiac pacemaker that sends electrical signals through wire electrodes implanted in the brain. For movement disorders the targets are brain structures important for motor control. Rigidity, tremor and dopamine-induced dyskinesia in Parkinson’s disease are treated at the subthalamic nucleus (STN) or the internal segment of the globus pallidus (GPi). The ventral intermediate nucleus of the thalamus (VIM) is used for essential tremor and for tremor as a primary symptom of Parkinson’s disease.

History (as reported):

  • 1950s: Surgical ablation of the VIM was already a therapy for tremor. Bilateral thalamotomy is not well tolerated because of the risk of speech and swallowing deficits (JAMA Neurology review).
  • 1987: Benabid and colleagues published thalamic stimulation contralateral to thalamotomy in patients with tremor. The JAMA Neurology review says this heralded the modern era of DBS. NINDS dates Benabid’s reports of reversible tremor reduction by VIM stimulation to 1987 to 1991.
  • 1997: FDA approved thalamic DBS for essential tremor and for severe tremor in Parkinson’s disease.
  • STN and GPi DBS for Parkinson’s disease: the two sources disagree on the year. NINDS gives 2002. The JAMA Neurology review gives 2003.
  • 2003: humanitarian device exemption for STN and GPi DBS in dystonia (both sources).
  • 2009: humanitarian device exemption for obsessive-compulsive disorder (JAMA Neurology review).

Why it matters here: DBS has the longest clinical track record of any chronic brain implant, and the review says its therapeutic mechanism remains under debate.

Limits: This is a history entry. No single device is specified, so there are no lead dimensions, contact counts or 3D model. The review is from 2012, so later approvals are not covered.

Spec Card Grid

Targets and indications

  • VIM thalamus: essential tremor, tremor in Parkinson’s disease
  • STN and GPi: Parkinson’s disease, dystonia (HDE)
  • Psychiatric: obsessive-compulsive disorder (HDE, 2009 per the review)

Regulatory

  • 1997: thalamic DBS for tremor
  • 2002 (NINDS) or 2003 (JAMA Neurology): STN and GPi for Parkinson’s disease
  • 2003: dystonia HDE

Evidence and limits

  • Not covered here: lead and pulse generator specifications; developments after 2012; no 3D model yet

References